LEUVEN, Belgium, LUND, Sweden and BASEL, Switzerland, June 18 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and BioInvent International AB (Nordic Exchange: BINV) announce that they have…

SAN DIEGO, June 17 /PRNewswire/ -- - Strong Government Support Continues to Draw Top Research Institutes, Talent, and Corporate Labs That Are Looking to Place Strategic Bets for the Future Singapore…

STOCKHOLM, June 17 /PRNewswire/ -- Axelar AB today announced that the company recently has initiated a phase I/II clinical trial on cancer patients with its new anti-cancer drug AXL1717, an insulin-…

A new study published today in Annals of Internal Medicine has good news for coffee drinkers: Regular coffee drinking (up to 6 cups per day) is not associated with increased deaths in either men or…

CHELTENHAM, England, June 14 /PRNewswire/ -- - With Photo Children from Bishop Stortfor College, Hornsby House School in South London and The Catholic School of St Gregory The Great in Cheltenham…

BEERSE, Belgium, June 14 /PRNewswire/ -- - 30 Percent Complete Response Rate Compared to 4 Percent With Current Drug Treatment Standard of Care - Abstract Number: 0473 Janssen-Cilag / Ortho Biotech…

PLEASANTON, California, June 13 /PRNewswire/ -- - Test offers more reliable detection of Chlamydia trachomatis, the most commonly reported sexually transmitted disease in Europe. Roche announced…

PARIS and AACHEN, Germany, June 13 /PRNewswire/ -- Results from two phase III clinical studies of tapentadol immediate release tablets (IR) suggest a significantly improved gastrointestinal…

PARIS, June 13 /PRNewswire/ -- - Rheumatoid Arthritis is the Leading Cause of Work Disability in Europe New data announced today showed that treating patients with early, active rheumatoid arthritis…

PARIS, June 13 /PRNewswire/ -- Seven-year rheumatoid arthritis (RA) data from open-label extension studies show that treatment with Abbott's HUMIRA(R) (adalimumab) resulted in clinical remission…